PULMATRIX, INC. Restricted Cash and Investments
PULMATRIX, INC. (PULM) had Restricted Cash and Investments of $1.47 million as of 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Balance Sheet › Assets › Restricted Cash and Investments
us-gaap:RestrictedCashAndInvestments · last filed 2022-11-10
- 2022-09-30: Restricted Cash and Investments $1.47M.
- 2022-06-30: Restricted Cash and Investments $1.47M.
- 2021-09-30: Restricted Cash and Investments $204.00K.
- 2021-06-30: Restricted Cash and Investments $204.00K.
| Period end | Restricted Cash and Investments |
|---|---|
| 2022-09-30 | $1.47M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $1.47M 10-Q · filed 2022-08-10 |
| 2021-09-30 | $204.00K 10-Q · filed 2022-11-10 |
| 2021-06-30 | $204.00K 10-Q · filed 2022-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |